| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 49,771 | 37,008 | 32,270 | | Cost of Revenue | 32,600 | 27,009 | 25,406 | | | Gross Profit | 17,171 | 9,999 | 6,864 | | | Operating Expenses | | Research Development | 2,366 | 2,878 | 3,095 | | Selling General and Administrative | 15,424 | 15,253 | 13,575 | | Non Recurring |
-
|
-
| 3,811 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (619) | (8,132) | (13,617) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (94) | 884 | 895 | | Earnings Before Interest And Taxes | (713) | (7,248) | (12,722) | | Interest Expense | 141 | 72 |
-
| | Income Before Tax | (854) | (7,320) | (12,722) | | Income Tax Expense | 86 | (114) | (351) | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (940) | (7,206) | (12,371) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (940) | (7,206) | (12,371) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($940) | ($7,206) | ($12,371) |
|
0.51% Nasdaq 
Income Statement
